Balanced news tone
News Sentiment
ENOV sentiment intelligence
Enovis Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
63 relevant articles
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+14.4% over one week, +18.1% over four weeks, trend inactive, and below fair value.
Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
80/100 classification
One-week reaction
14.4%
Price confirming higher
Trend fit
Trend inactive
18.1% over four weeks
Fair value
-36.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
20
Neutral
38
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 00:57
- Source
- GuruFocus
StockStory
Industry context
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 10:54
- Source
- StockStory
Market source
Direct company coverage
Enovis (ENOV) Stock Trades Up, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 22:38
- Source
- Market source
GlobeNewswire
Direct company coverage
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
Enovis's Companion Animal Health business has launched CT-RevitL™, a new veterinary laser therapy system, in the U.S. This next-generation system aims to deliver deeper, faster, and more consistent therapeutic outcomes for animals, built on extensive research in photobiomodulatio
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 13 Jul 2026 16:11
- Source
- GlobeNewswire
Vet Candy
Direct company coverage
Enovis Launches New Veterinary Laser Therapy System in the U.S.
Enovis Corporation has launched CT-RevitL™, a new veterinary PBM laser therapy system in the U.S., through its Companion Animal Health business. This system aims to provide enhanced clinical performance, greater mobility, and a more intuitive treatment experience for veterinary t
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 13 Jul 2026 13:42
- Source
- Vet Candy
Investing.com
Direct company coverage
Enovis launches veterinary laser therapy system in U.S.
Enovis Corporation launched CT-RevitL, a new veterinary laser therapy system, in the U.S. This system uses photobiomodulation to manage pain, accelerate healing, and reduce inflammation in animals. The launch includes a clinical education program, and the company plans for intern
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 13 Jul 2026 13:40
- Source
- Investing.com
Stock Titan
Direct company coverage
New CT-RevitL laser aims to speed pain relief and healing for pets
Enovis' Companion Animal Health has launched CT-RevitL, a new veterinary photobiomodulation (PBM) laser therapy system in the U.S. This system is designed to provide deeper, faster, and more consistent therapeutic outcomes for animals, leveraging over 150 published PBM studies an
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 13 Jul 2026 12:40
- Source
- Stock Titan
Simply Wall Street
Direct company coverage
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile?
Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Value-Defensive and Defensive Indexes on June 27, 2026, indicating a potential shift in its risk and style classification within the small-cap universe. This exclusion prompts a reevaluation of the company's invest
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 15:40
- Source
- Simply Wall Street
MT Newswires
Direct company coverage
BMO Capital Initiates Enovis at Outperform With $29 Price Target
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 09 Jul 2026 12:24
- Source
- MT Newswires
Stock Titan
Direct company coverage
American Century affiliates report 10.6% holdings in Enovis (ENOV)
American Century Investment Management, Inc. and American Century Companies, Inc. have reported a 10.6% beneficial ownership stake in Enovis Corporation (ENOV) through an amended SCHEDULE 13G/A filing. Separately, American Century Capital Portfolios, Inc. holds 4.7% of Enovis com
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 14:39
- Source
- Stock Titan
Simply Wall Street
Direct company coverage
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus
Enovis (ENOV) has experienced a sharp stock price increase following the Centers for Medicare & Medicaid Services' reversal of planned reimbursement cuts for its noninvasive bone growth stimulators. Despite years of weak shareholder returns, this regulatory decision has put the c
- Tone
- Positive 70/100
- Event
- Regulatory and legal
- Published
- 07 Jul 2026 23:09
- Source
- Simply Wall Street
The Globe and Mail
Direct company coverage
Why Enovis (ENOV) Stock Is Trading Up Today
Shares of medical technology company Enovis Corporation (ENOV) surged 15% after the Centers for Medicare & Medicaid Services reversed previously announced reimbursement cuts for the company's non-invasive bone growth stimulators. This decision, coupled with broader strength in th
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 07 Jul 2026 02:20
- Source
- The Globe and Mail
Moomoo
Direct company coverage
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $32
Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) but has reduced the target price for the stock to $32. The revision indicates the firm's continued positive outlook on the company despite potential adjustments to its valuation.
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 06 Jul 2026 15:40
- Source
- Moomoo
Investing.com
Direct company coverage
Enovis shares jump after Medicare reverses reimbursement cuts
Enovis Corp shares rose approximately 11% following Medicare's reversal of previously announced reimbursement cuts for the company’s non-invasive bone growth stimulators. The decision by the Centers for Medicare & Medicaid Services positively impacted the company's stock. This ar
- Tone
- Positive 94/100
- Event
- Market update
- Published
- 06 Jul 2026 15:09
- Source
- Investing.com
Moomoo
Direct company coverage
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $39
BTIG has reiterated its Buy rating for Enovis Corp (ENOV.US) and maintained a target price of $39. This indicates that BTIG continues to have a positive outlook on the company's stock performance.
- Tone
- Positive 76/100
- Event
- Analyst action
- Published
- 06 Jul 2026 14:40
- Source
- Moomoo
Stock Titan
Direct company coverage
Enovis (ENOV) director Christine Ortiz receives 846-share stock award
Enovis (ENOV) director Christine Ortiz was granted 846 shares of common stock on June 30, 2026, as a compensation-related award with a stated price of $0.00 per share. This transaction increased her direct holdings to 25,857 shares of Enovis common stock. The Form 4 filing indica
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 01:40
- Source
- Stock Titan
Investing.com UK
Direct company coverage
Form 4 Enovis Corp For: 1 July By Investing.com
This article from Investing.com UK is a Form 4 filing for Enovis Corp, dated July 1st. It provides a brief mention of the company (ENOV) and its stock performance (+12.28%), alongside extensive financial market data and news headlines. The content primarily focuses on market move
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 01:09
- Source
- Investing.com UK
Simply Wall Street
Direct company coverage
How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing
Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Defensive and Value-Defensive Indices on June 27, 2026, which may lead to short-term trading volatility as index-tracking funds rebalance. The article notes that this removal does not change Enovis's core strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 00:13
- Source
- Simply Wall Street
Investing.com
Direct company coverage
Enovis stock hits 52-week low at 20.45 USD
Enovis Corporation's stock has fallen to a 52-week low of $20.45, representing a 37.1% decrease over the past year and placing it 44% below its 52-week high. Despite this decline, InvestingPro analysts suggest the stock is undervalued, predicting future profitability and setting
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 30 Jun 2026 15:09
- Source
- Investing.com
Simply Wall Street
Direct company coverage
Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84%
Enovis (ENOV) recently reported an 84.34% year-over-year increase in net profit on quarterly revenue of US$589.15 million, suggesting it could be significantly undervalued by 46% according to certain models, trading at US$22.71 against a fair value of US$42.30. Despite a weak yea
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 27 Jun 2026 14:42
- Source
- Simply Wall Street
TradingView
Direct company coverage
Enterprise value to revenue forward of Enovis Corporation – NYSE:ENOV
This article provides a brief financial snippet for Enovis Corporation (NYSE: ENOV), displaying its enterprise value to revenue forward. It indicates the period, value, and change percentages for this financial metric. The content is presented by TradingView and includes standard
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 00:10
- Source
- TradingView
TradingView
Direct company coverage
Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
This page provides financial actuals and estimates for Enovis Corporation (E2NO34) on the BMFBOVESPA exchange. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. Users can compare actual results with
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 16:09
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to EBITDA forward of Enovis Corporation – NYSE:ENOV
The article focuses on the enterprise value to EBITDA forward for Enovis Corporation (NYSE: ENOV). It appears to be a financial data snippet from TradingView, providing a period, value, and change for this specific financial metric. The content is presented within the context of
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 13:09
- Source
- TradingView
TradingView
Direct company coverage
Price to earnings forward of Enovis Corporation – NYSE:ENOV
The article displays the "Price to earnings forward" metric for Enovis Corporation (NYSE: ENOV). It shows that for the displayed period, the value was 'No trades', indicating no recent trading activity for this specific financial metric. The content is primarily a data point pres
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 03:41
- Source
- TradingView
TradingView
Direct company coverage
Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:E2NO34)
This article provides an overview of Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E2NO34) on the BMFBOVESPA exchange, focusing on its financial actuals and estimates. It highlights that users can explore reported financial data and analyst estimat
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 26 Jun 2026 00:41
- Source
- TradingView
Finviz
Direct company coverage
ENOV - Enovis Corp Short Interest
This article provides a detailed financial overview of Enovis Corp (ENOV), including its last closing price, market capitalization, income, sales, and various financial ratios. It also highlights short interest data, insider and institutional ownership, and stock performance over
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 25 Jun 2026 11:10
- Source
- Finviz
TradingKey
Direct company coverage
Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis
Enovis Corp (ENOV) has a current financial score of 6.28, placing it 164th out of 204 in the Healthcare Equipment & Supplies industry, indicating weak financial status but average operating efficiency. The company recently reported a quarterly revenue of $589.15M, a 5.43% year-ov
- Tone
- Positive 61/100
- Event
- Earnings
- Published
- 24 Jun 2026 09:11
- Source
- TradingKey
TradingKey
Direct company coverage
Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Enovis Corp (ENOV), detailing its current price momentum score, support and resistance levels. It reviews various technical indicators like MACD, RSI, and moving averages, all of which currently suggest a "Sell" signal for the stock.
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Jun 2026 05:09
- Source
- TradingKey
Intellectia AI
Direct company coverage
ENOV Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Enovis Corp (ENOV), indicating a "Strong Sell" consensus based on various technical indicators and moving averages. The analysis highlights key support and resistance levels, momentum indicators like RSI and
- Tone
- Negative 26/100
- Event
- Guidance
- Published
- 23 Jun 2026 02:40
- Source
- Intellectia AI
Stock Titan
Direct company coverage
Enovis (ENOV) CAO adds 1,000 shares in $20.92 open-market buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Stock Titan